|
Afexa Life Sciences, Inc. Statement
The following statement was sent to the Marketplace website on Jan. 14, 2012, from Afexa Life Sciences, Inc., the makers of COLD-FX. Afexa was taken over late last year by Valeant Pharmaceuticals International.
We at Afexa Life Sciences stand behind COLD-FX, the clinical trials establishing the safety and efficacy of the product in helping reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system, and the brand's proud Canadian heritage.
No product failing to meet Health Canada criteria has ever been released for sale by the Company. Any products found not to meet our stringent quality standards are destroyed. We invite you to visit the following pages for Afexa's perspective on the issues: Our proud Canadian heritage: http://coldfx.ca/proudCanadian.htm The clinical evidence: http://coldfx.ca/res/clinical-trials Our safety standards: http://coldfx.ca/health_chembioprint.htm Note: CBC does not endorse and is not responsible for the content of external links. |
![]() |